用卡伯戈林治疗的前乳腺瘤患者肺部副作用的评估
Ozlem Soyluk1, Zuleyha Bingol2, Sema Ciftci3
1Division of Endocrinology and Metabolism, Department of Internal Medicine, Istanbul Medical Faculty, Istanbul University, Istanbul, Türkiye. drozlem76@hotmail.com.
Endokrynologia Polska
|August 14, 2023
概括
卡伯戈林 (CAB) 对益乳瘤患者是安全的,没有显著的肺部副作用. 这种多巴胺激动剂没有证明异常肺功能测试和累计CAB剂量之间的关联.
科学领域:
- 内分泌学 在内分泌学.
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 卡伯戈林 (CAB) 是治疗前乳腺瘤的主要多巴胺激动剂.
- 用于帕金森病的多巴胺激动剂与纤维化综合征有关.
- 在益生菌瘤患者中,CAB的肺部副作用需要评估.
研究的目的:
- 评估卡伯戈林 (CAB) 在患有前性腺瘤的患者的潜在肺部副作用.
- 为了研究CAB剂量与肺功能之间的关系.
主要方法:
- 追溯分析了73名益生菌瘤患者.
- 评估胸部X射线和肺功能测试 (FVC,TLC,DLCO).
- 累计CAB剂量和使用时间的计算.
主要成果:
- 在64个月内,累计CAB剂量的中位数为192毫克.
- 17%的患者表现出异常的DLCO,这是肺纤维化潜在的迹象.
- 异常的DLCO与累计CAB剂量没有相关性.
结论:
- 卡伯戈林 (CAB) 在益生菌瘤患者中证明了肺安全性.
- 肺功能似乎不受CAB的影响,即使在大量的累积剂量.
相关概念视频
Parkinson's Disease: Treatment
299
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
299
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
396
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
396
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
332
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
332
Direct-Acting Cholinergic Agonists: Therapeutic Uses
791
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
791
Drugs for Treatment of Constipation-Predominant IBS
210
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
210
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
215
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
215


